Amphastar Insider Sale: What Richard Prins’ 7,973 Shares Mean for Investors
Amphastar insider sale analysis: Why Richard Prins’ 7,973‑share divestiture matters for investors, pipeline prospects, and competitive dynamics.
- AMPHASTAR PHARMACEUTICALS IN
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read